GoDubai
  
  
  
  
Citylife > Press Release
  Home Contact us Add to Favourites
Most Recent Postings
More Press Releses
Featured Sections

Event Finder
A daily roundup of exhibitions, promotions and other events in Dubai and the rest of the Emirates.
Submit an Event
Latest Dubai Press Releases >> Healthcare, Fitness and Medicine

 
  Share
  • First and only medicine approved to treat two types of MS: relapsing forms of MS (RMS) and PPMS 
  • First and only approved disease-modifying therapy for primary progressive multiple sclerosis (PPMS), one of the most disabling forms of MS   
  • First and only approved MS treatment to target the immune cells, thought to be responsible for the damage that leads to disability 
Dubai, 10th July, 2018:   OCREVUS™ (ocrelizumab), a first of its kind therapy for both relapsing (RMS) and primary progressive forms of multiple sclerosis (PPMS), amongst the most disabling forms of MS, is now available in the UAE. Offering renewed hope to patients across the Emirates, the therapy, launched by Roche Pharmaceuticals and approved in August 2017 by the UAE Ministry of Health and Prevention (MOHAP), is the first and only disease-modifying approved therapy available world-wide that targets both forms of PPMS and RMS. OCREVUS™ (ocrelizumab) is also a superior to another therapy, as studies show, it reduced signs of disease activity and slowed the disability progression considerably .
 
MS is a chronic autoimmune disorder for which there is currently no cure . It occurs when the immune system abnormally attacks the protection cover around the nerve cells in the brain, spinal cord and optic nerves, causing inflammation (lesions) and consequent damage to the way nerves work. MS is a lifelong condition, but not a terminal illness . Anyone can develop MS; however, it is more common in people with a family history of it, more prevalent in women than men, and usually diagnosed when people are in their 20s and 30s .  
 
The symptoms resulting from the damage can range from muscle weakness, fatigue, vision loss, bladder incontinence, unsteadiness and difficulty walking, to eventual disability. It is the most common cause of disability in young people globally . There are two forms of the disease, PPMS and relapsing-remitting multiple sclerosis (RMS). Approximately 85 percent of people with MS are initially diagnosed with RMS, while 15 percent are diagnosed with PPMS . RMS, the most common form of MS, is characterised by episodes of new or worsening signs or symptoms (relapses) followed by periods of recovery   . PPMS, the more debilitating form of the disease, is marked by steadily worsening symptoms, typically without distinct relapses or periods of remission .
 
“Until now, people affected by PPMS didn't have any treatment options, which only left patients to hope that the disease wouldn't aggressively progress. Now, those living with PPMS could hope to enjoy a perceptible improvement in their quality of life, thanks to slower disability progression and reduced signs of damage in the brain,” said Abed Sabra, General Manager, Roche Pharmaceuticals in the UAE.
 
“While this is a milestone moment for the MS community and Roche, there is still much more to be done to improve the lives of people living with the condition. Increased public awareness around the disease is a must for helping patients come to terms and cope with the disease, and feel better understood and supported,” urged Abed. 
 
A persistent myth about MS is that once diagnosed people should give up work, physical activity, and not have children . However, this is not true: MS is a life-long condition, with which people can still live a full life . 
 
Mr Ahmed Al Miskari, who is Head of Patient Affairs at the Multiple Sclerosis Foundation in Al Ain and also suffers from MS, explained: “Very often, individuals with MS suffer from depression, leave their careers, experience emotional stress and become socially withdrawn. These things are avoidable as it's becoming easier for people with MS to live a full, rewarding and enjoyable life as an active member of the community. I encourage all MS patients to seek support, and also help foster increased public awareness about the disease.” 
 
OCREVUS™ (ocrelizumab) is unique in the way it targets the immune cells, thought to be responsible for the damage (lesions) that lead to disability, while allowing the immune system to continue functioning. It has also been proven to be an important and more effective new treatment option for people with relapsing forms of MS . As shown by studies in patients with RMS, compared with another therapy, it reduced attacks per year by nearly half, more effectively decreased signs of disease activity, and was better at slowing disability progression over the two-year controlled treatment period . Forty percent of patients with RMS were less likely to have disability progression . In patients with PPMS, compared with a placebo, OCREVUS was the first and only treatment to significantly slow disability progression over a median treatment duration of three years . Twenty four percent of people with PPMS were less likely to have disability progression, and 39 percent saw the volume of their lesions (damage in the brain) reduced . 
 
His Excellency, Dr. Amin Hussain Al Amiri, Assistant Undersecretary for Medical Practice and License Sector at the Ministry of Health & Prevention (MOHAP) in the UAE, said: “Patients' welfare is at the heart of our mission, which is why we are welcoming innovations like this into our market, as they make a real difference to patients' and their family's lives, health and happiness.”
 
Data on the number of MS patients in the UAE is unfortunately scarce, outdated, and mostly specific to a limited number of medical facilities . A SEHA study, conducted between 2010 and 2014 in four key public hospitals in Abu Dhabi, found there were 510 people living with MS . However, this number is expected to be higher due to all the unreported cases. The crude prevalence rate of MS in Abu Dhabi is estimated to be 18 people per 100,000 , whereas in the Emirati population alone it is expected to reach 64 people per 100,000 . 
 
Dr Ahmed Shatila, Neurology Consultant, Mafraq Hospital in Abu Dhabi, added: “It is wonderful to see such improvements and innovations in the treatment and management of MS. It is crucial of course to raise awareness about the different treatment options patients have, but the most important factor to me is the dialogue between the doctor and the patient. As a doctor, I can't stress enough to patients how important it is to ask the right questions, not only when first diagnosed but also during the course of their lifetime.” 
 
Dr Shatila suggests the following questions to help patients with MS start the conversation with their doctor around optimising quality of life: 
  • How frequently does this suggested therapy require monitoring and testing?
  • Will this therapy allow me to continue doing the things I am passionate about (i.e. traveling)?
  • How much compliance will this therapy need from me? I.e. What happens if I am busy and forget a dose?
  • What can I do to improve my quality of life?
  • What are things my family can do to help me live a better life?
  • What are things I can do to prevent added stress and emotional burden?
  • Can I still play sports?
  • Is there anything special I should consider with regards to family planning?
  • How can I explain my condition in simple terms to my employer and/ or family?
To further raise awareness about the therapy, Roche recently held a workshop in the UAE with healthcare professionals and key stakeholders. 



Posted by : GoDubai Editorial Team
Viewed 6631 times
Posted on : Tuesday, July 10, 2018  
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of GoDubai.com.
Previous Story : HP Collaborates with Abu Dhabi's Danat Al Emarat Hospital to Re-invent Patients' Experience
Next Story : Medeor 24x7 International Hospital Al Ain Signs MoU with Fatima College of Health Sciences
Email this article Print this article

Share this article with your friends and followers
NewsVine

Comments

Back to Top  
Most Viewed Press Release posted in the last 7 days
NARS Erdem SS19 Beauty Report
Diana Arno Expands Online Shopping to Middle East
Introducing Home Fragrance at Robinsons, Dubai Festival City
Introducing VK Beauty Lounge & Bar
Defying Age With Skin Republic's Gold and Platinum Face Masks
The Future Is Here
Roberto Cavalli's Exclusive Duo of Fragrances
Lacoste.12.12 Collection
Bring a Touch of Sophistication to Your Home with The Exclusive SmegXDolce&Gabba...
FOREO To Attend TFWA: the World's Largest Travel Retail Show
Trevor Sorbie Range Relaunches in the UAE
Dubai Parks and Resorts Celebrates Saudi National Day
Honor Set to Go Beyond Limits With the Launch of Honor 8x
Carl F. Bucherer Celebrates Debut of Its Online Boutique on Jd.Com Launch of Lim...
O Boticário Opens in Dubai its First Amphora Store outside Brazil Come Join...
Pamper yourself at Perfumery & Co this month, at The Dubai Mall
The Mummies of Dubai Give Their Kids a Preppy Style Makeover
GROHE Smart Home: The App-Controlled Water Security System
Huawei Deepens Cooperation with Duisburg to Transform Germany's Industrial Hear...
Ministry of Human Resources and Emiratisation, Huawei and Honor launch ICT Compe...
New GUESS Handbags for FW18
Le Meridien Dubai Hotel & Conference Centre's Restaurant Promotions- October
Hyperloop Transportation Technologies, Partners, and Government Stakeholders Mov...
William Collection by Hugo Boss
Al-Futtaim ACE launches its stylish new Outdoor collection
du Wins Smart Cities Award at the Telecoms World Middle East 2018
Tips & Toes Hits the Big 3-5!
Honda voted “Preferred Sedan Car Brand of the Year” for the fourth year in a row
Al-Futtaim Toyota swoops another win at the Filipino Times Awards
Dubai Design Week continues to grow, cementing Dubai as the design capital of t...
Eberhard & Co. Scafograf 100 For Elegant Lady
Mousses Etoiles to reveal the latest luxury designs of commercial-use outdoor fu...
Tata Communications launches a specialised cyber security lab at Shanmugha Arts,...
Consonni Wraps Up La Vuelta a Espana With a Seventh Place Finish for UAE Team Em...
Abu Dhabi wins bid to host 2022 ITU Grand Final in world first
Akamai Unveils Solutions at IBC 2018 Designed to Mitigate the Challenges and Cos...
Cadillac XT4 Delivers Dynamic Driving Experience
WWE® Crown Jewel Set for November 2 in Saudi Arabia
du Opens New Business Centre in DIFC for Enterprise Customers
New Homologations for Pirelli Tyres
The Ferrari Monza SP1 and SP2 unveiled – the first models in a new concept of li...
Volunteers from the UAE join hands with the community in Tasset Peulh village in...
Sharjah's Recognition as ‘Accessible City for Physically Disabled' Hailed as His...
Dubai Festival City Mall Celebrates KSA National Day with Special Imagine Show
2018 FW in style at Zippy
The Dubai Business Women Council meets with the UN Assistant Secretary-General t...
Fidu Properties unveils second office in Dubai; eyes expansion in UAE
Registration for the 5th edition of Camel Trek is now open
New Headmaster for Repton School, Abu Dhabi School's Rose Campus (FS1 to Year 1...
Huawei becomes one of the first multi-national technology companies to register ...